KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Inventory Average (2016 - 2025)

Historic Inventory Average for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Q3 2025 value amounting to $61.7 million.

  • Supernus Pharmaceuticals' Inventory Average fell 659.47% to $61.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.7 million, marking a year-over-year decrease of 659.47%. This contributed to the annual value of $65.9 million for FY2024, which is 2204.69% down from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Inventory Average stood at $61.7 million, which was down 659.47% from $46.7 million recorded in Q2 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Inventory Average peaked at $91.3 million during Q1 2023, and registered a low of $46.7 million during Q2 2025.
  • For the 5-year period, Supernus Pharmaceuticals' Inventory Average averaged around $71.8 million, with its median value being $73.1 million (2021).
  • Its Inventory Average has fluctuated over the past 5 years, first surged by 9306.31% in 2021, then crashed by 3475.99% in 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Inventory Average (Quarter) stood at $73.1 million in 2021, then increased by 19.57% to $87.4 million in 2022, then decreased by 7.91% to $80.4 million in 2023, then decreased by 26.49% to $59.1 million in 2024, then increased by 4.35% to $61.7 million in 2025.
  • Its last three reported values are $61.7 million in Q3 2025, $46.7 million for Q2 2025, and $51.9 million during Q1 2025.